|
Tarasova O.A., Chulkov V.S., Ektova N.A., Chulkov Vl.S.
Polymorphic variants of renin-angiotensin-aldosterone system genes in female patients with a history of arterial hypertension during pregnancy and their association with metabolic syndrome
|
№2 / 2024
|
|
Aryamkina O.L., Dobrynina I.Yu., Biek A.Yu., Saitov A.R., Tarasova L.V., Zapevalov A.V., Grishmanovsky P.V., Grishmanovskaya O.N.
Possibilities for diagnostics of non-alcoholic fatty liver disease in patients with metabolically associated comorbid pathology
|
№7 / 2023
|
|
Kislyak O.A., Mikaelyan A.A., Starodubova A.V., Kosyura S.D.
Cardiovascular and metabolic risks in patients with obesity and non-alcoholic fatty liver disease
|
№3 / 2023
|
|
Mazurov V.I., Gaydukova I.Z., Tsinzerling A.Yu., Bashkinov R.A., Inamova O.V., Petrova M.S.
The effect of asymptomatic hyperuricemia on the frequency and structure of comorbidity patients with rheumatoid arthritis
|
№6 / 2022
|
|
Gosteva E.V., Vasilyeva L.V., Suslova E.Yu., Inshakova K.Yu.
Association of cardiovascular risk factors and vitamin D status in patients with metabolic syndrome
|
№4 (приложение) / 2022
|
|
Alieva A.M., Baykova I.E., Khadzhieva N.H., Ettinger O.A., Arakelyan R.А., Valiev R.K., Rakhaev A.M., Batov М.А., Elmurzaeva D.А., Malkarova D.S., Nikitin I.G.
Resistin and cardiovascular pathology
|
№9 / 2021
|
|
Korneeva E.V., Voevoda M.I., Semaev S.E., Maksimov V.N.
Clinical significance of gene polymorphisms in the development of metabolic syndrome in the young population
|
№9 / 2021
|
|
Non-alcoholic fatty liver disease in adults: clinic, diagnostics, treatment (clinical guidelines for therapists, third version)
|
№7 / 2021
|
|
Alikova S.K., Ranyuk L.G., Burduli N.M., Tadtaeva D.J.
Hemodynamic types of microcirculation and laser therapy in chronic pancreatitis in combination with metabolic syndrome
|
№3 / 2019
|
|
Koroy P.V., Slyadnev S.A., Kravchenko Yu.A., Yagoda A.V.
Influence of metabolic syndrome on course of non-alcoholic fatty liver disease
|
№3 / 2019
|
|
Tadtaeva D.J., Ranyuk L.G., Alikova S.K., Burduli N.M.
Cytogenetic changes and lipid peroxidation in patients with gastroesophageal reflux disease in combination with metabolic syndrome
|
№3 / 2019
|
|
S.N. Tolpygina
Possibility of high-selective adrenoblockers use in combined therapy ofpatients with metabolic syndrome
|
№4 / 2018
|
Русский
